BBLN Stock Price, News & Analysis

Summary not available.

Summary not available.

Summary not available.

Babylon (NYSE: BBLN) will host a conference call on May 10, 2023, at 8:00 AM Eastern Time, to discuss its first quarter financial results. A press release detailing the results will be available before the call. Participants can join by dialing (877) 407-7994 for the U.S., 0 800 756 3429 for the U.K., or +1 215-268-9868 internationally. Alternatively, the call will be accessible via a live webcast at babylonhealth.com. Babylon aims to revolutionize healthcare accessibility through its digital primary care services across 15 countries, supporting a diverse patient network and operational capabilities in 16 languages.

Babylon (NYSE: BBLN) has launched personalized, digital-first programs for high-risk members with chronic conditions, including diabetes, hypertension, and prenatal care. These initiatives are designed to provide evidence-based, real-time monitoring and support through integrated care teams. The company's technology gathers data to enhance patient engagement and health management. Babylon aims to improve health outcomes while reducing acute events and hospitalizations.

With a focus on empowering patients, Babylon's programs offer tailored care plans and ongoing support, particularly for underserved populations in rural areas. The company continues to expand its services globally.

Babylon Holdings Limited (NYSE: BBLN) reported significant financial growth for 2022, with revenue rising 3.5x year-over-year to $1.11 billion. The U.K. clinical services achieved profitability, and U.S. clinical services are expected to follow suit early in 2023. Key U.S. value-based care (VBC) contracts generated profitable medical margins in their first year. While Q4 2022's adjusted EBITDA was $(16.3) million, it outperformed expectations. The company anticipates achieving adjusted EBITDA profitability by mid-2024, earlier than previously forecasted. Babylon also introduced a new digital-first Commercial Exchange product, expanding its VBC membership significantly.

Babylon (NYSE: BBLN) will host a conference call on March 9, 2023, at 8:00 AM ET to discuss its fourth quarter and full year 2022 financial results. The company will issue a press release with the results prior to the call. Participants can join by dialing specified numbers for U.S., U.K., and international attendees or by accessing the live webcast on the Babylon investor relations website. Babylon is committed to making healthcare accessible globally, leveraging its digital-first primary care services across 15 countries and supporting operations in 16 languages.

Babylon Holdings Limited (NYSE: BBLN) anticipates revenue exceeding $1.05 billion for the year ending December 31, 2022, including its California IPA business. The company expects to outperform its previously estimated IFRS Adjusted EBITDA loss of $(270) million. Following cost-cutting measures, Babylon aims for an additional $100 million in annual savings. Transitioning to U.S. GAAP reporting status, the company will announce its Q4 and year-end results under this new format.

Babylon (NYSE: BBLN) has announced a 1-for-25 reverse share split of its Class A ordinary shares, effective December 15, 2022. This measure aims to boost the share price to comply with NYSE minimum requirements and attract institutional investors. Following the split, the share capital will total US$409,896.05, with new par values set at US$0.001056433113 for both Class A and Class B shares. Babylon’s shares will continue trading under the symbol 'BBLN', and fractional shares will be sold, with cash payments made to affected shareholders.